# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-25-060362
Filing Date
2025-04-29
Accepted
2025-04-29 17:30:14
Documents
15
Period of Report
2025-06-24

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | ck0001534133-20250429.htm iXBRL | DEF 14A | 1655878
2 | GRAPHIC | img248107157_0.jpg | GRAPHIC | 5133
3 | GRAPHIC | img248107157_1.jpg | GRAPHIC | 4145366
4 | GRAPHIC | img248107157_2.jpg | GRAPHIC | 625637
| Complete submission text file | 0000950170-25-060362.txt |  | 13679075

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | ck0001534133-20250429.xsd | EX-101.SCH | 15156
17 | EXTRACTED XBRL INSTANCE DOCUMENT | ck0001534133-20250429_htm.xml | XML | 17055

Mailing Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037
Business Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037 858-952-5500
CalciMedica, Inc. (Filer) CIK: 0001534133 (see all company filings)

EIN.: 452120079 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39538 | Film No.: 25889667
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)